Diagnostic assays for identification of anaplastic lymphoma kinase-positive nonsmall cell lung cancer

被引:60
作者
Weickhardt, Andrew J. [1 ]
Aisner, Dara L. [2 ]
Franklin, Wilbur A. [2 ]
Varella-Garcia, Marileila [2 ]
Doebele, Robert C. [1 ]
Camidge, D. Ross [1 ]
机构
[1] Univ Colorado, Ctr Canc, Div Med Oncol, Aurora, CO USA
[2] Univ Colorado, Ctr Canc, Dept Pathol, Aurora, CO USA
关键词
crizotinib; nonsmall cell lung cancer; anaplastic lymphoma kinase (ALK); gene rearrangements; fluorescence in situ hybridization; IN-SITU-HYBRIDIZATION; EML4-ALK FUSION GENE; COPY NUMBER; ALK; REARRANGEMENT; INHIBITOR; DECALCIFICATION; BREAST; FISH; ADENOCARCINOMAS;
D O I
10.1002/cncr.27913
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In series dominated by adenocarcinoma histology, approximately 5% of nonsmall cell lung cancers (NSCLCs) harbor an anaplastic lymphoma kinase (ALK) gene rearrangement. Crizotinib, a tyrosine kinase inhibitor with significant activity against ALK, has demonstrated high response rates and prolonged progression-free survival in ALK-positive patients enrolled in phase 1/2 clinical trials. In 2011, crizotinib received accelerated approval from the US Food and Drug Administration (FDA) for the treatment of proven ALK-positive NSCLC using an FDA-approved diagnostic test. Currently, only break-apart fluorescence in situ hybridization testing is FDA approved as a companion diagnostic for crizotinib; however, many other assays are available or in development. In the current review, the authors summarize the diagnostic tests available, or likely to become available, that could be used to identify patients with ALK-positive NSCLC, highlighting the pros and cons of each. Cancer 2013. (c) 2012 American Cancer Society.
引用
收藏
页码:1467 / 1477
页数:11
相关论文
共 63 条
[21]   Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers [J].
Katayama, Ryohei ;
Shaw, Alice T. ;
Khan, Tahsin M. ;
Mino-Kenudson, Mari ;
Solomon, Benjamin J. ;
Halmos, Balazs ;
Jessop, Nicholas A. ;
Wain, John C. ;
Yeo, Alan Tien ;
Benes, Cyril ;
Drew, Lisa ;
Saeh, Jamal Carlos ;
Crosby, Katherine ;
Sequist, Lecia V. ;
Iafrate, A. John ;
Engelman, Jeffrey A. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (120)
[22]  
Khadija K, 2012, J CLIN ONCOL, V30
[23]   Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization with Correlation of ALK Protein Expression [J].
Kim, Hyojin ;
Yoo, Seol-Bong ;
Choe, Ji-Young ;
Paik, Jin Ho ;
Xu, Xianhua ;
Nitta, Hiroaki ;
Zhang, Wenjun ;
Grogan, Thomas M. ;
Lee, Choon-Taek ;
Jheon, Sanghoon ;
Chung, Jin-Haeng .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (08) :1359-1366
[24]   EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer [J].
Koivunen, Jussi P. ;
Mermel, Craig ;
Zejnullahu, Kreshnik ;
Murphy, Carly ;
Lifshits, Eugene ;
Holmes, Alison J. ;
Choi, Hwan Geun ;
Kim, Jhingook ;
Chiang, Derek ;
Thomas, Roman ;
Lee, Jinseon ;
Richards, William G. ;
Sugarbaker, David J. ;
Ducko, Christopher ;
Lindeman, Neal ;
Marcoux, J. Paul ;
Engelman, Jeffrey A. ;
Gray, Nathanael S. ;
Lee, Charles ;
Meyerson, Matthew ;
Janne, Pasi A. .
CLINICAL CANCER RESEARCH, 2008, 14 (13) :4275-4283
[25]   Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer [J].
Kwak, Eunice L. ;
Bang, Yung-Jue ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Solomon, Benjamin ;
Maki, Robert G. ;
Ou, Sai-Hong I. ;
Dezube, Bruce J. ;
Jaenne, Pasi A. ;
Costa, Daniel B. ;
Varella-Garcia, Marileila ;
Kim, Woo-Ho ;
Lynch, Thomas J. ;
Fidias, Panos ;
Stubbs, Hannah ;
Engelman, Jeffrey A. ;
Sequist, Lecia V. ;
Tan, WeiWei ;
Gandhi, Leena ;
Mino-Kenudson, Mari ;
Wei, Greg C. ;
Shreeve, S. Martin ;
Ratain, Mark J. ;
Settleman, Jeffrey ;
Christensen, James G. ;
Haber, Daniel A. ;
Wilner, Keith ;
Salgia, Ravi ;
Shapiro, Geoffrey I. ;
Clark, Jeffrey W. ;
Iafrate, A. John .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1693-1703
[26]  
LEBEAU MM, 1989, LEUKEMIA, V3, P866
[27]  
Li T, 2011, J CLIN ONCOL, V29
[28]   Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies [J].
Lipson, Doron ;
Capelletti, Marzia ;
Yelensky, Roman ;
Otto, Geoff ;
Parker, Alex ;
Jarosz, Mirna ;
Curran, John A. ;
Balasubramanian, Sohail ;
Bloom, Troy ;
Brennan, Kristina W. ;
Donahue, Amy ;
Downing, Sean R. ;
Frampton, Garrett M. ;
Garcia, Lazaro ;
Juhn, Frank ;
Mitchell, Kathy C. ;
White, Emily ;
White, Jared ;
Zwirko, Zac ;
Peretz, Tamar ;
Nechushtan, Hovav ;
Soussan-Gutman, Lior ;
Kim, Jhingook ;
Sasaki, Hidefumi ;
Kim, Hyeong Ryul ;
Park, Seung-il ;
Ercan, Dalia ;
Sheehan, Christine E. ;
Ross, Jeffrey S. ;
Cronin, Maureen T. ;
Jaenne, Pasi A. ;
Stephens, Philip J. .
NATURE MEDICINE, 2012, 18 (03) :382-384
[29]   Fusion of ALK to the ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor [J].
Ma, ZG ;
Hill, DA ;
Collins, MH ;
Morris, SW ;
Sumegi, J ;
Zhou, M ;
Zuppan, C ;
Bridge, JA .
GENES CHROMOSOMES & CANCER, 2003, 37 (01) :98-105
[30]   ALKoma: A Cancer Subtype with a Shared Target [J].
Mano, Hiroyuki .
CANCER DISCOVERY, 2012, 2 (06) :495-502